Star Lake Bioscience Company Overview

  • Year Founded
  • 1964

Year Founded

  • Status
  • Public

  • Employees
  • 10,528

Employees

  • Stock Symbol
  • 600866

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.64
  • (As of Thursday Closing)

Star Lake Bioscience Company General Information

Description

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No.67,Gongnong Road North
  • Zhaoqing, Guangdong 526040
  • China
+86 0758
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Commodity Chemicals
Stock Exchange
SHG
Corporate Office
  • No.67,Gongnong Road North
  • Zhaoqing, Guangdong 526040
  • China
+86 0758

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Star Lake Bioscience Company Stock Performance

As of 19-Nov-2026, Star Lake Bioscience Company’s stock price is $0.64. Its current market cap is $1.06B with 1.66B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.64 $0.65 $0.58 - $1.20 $1.06B 1.66B 22.8M

Star Lake Bioscience Company Financials Summary

As of 30-Sep-2026, Star Lake Bioscience Company has a trailing 12-month revenue of $2.34B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,925,282 2,075,893 1,744,146 1,496,228
Revenue 2,340,226 2,211,012 2,415,791 2,455,692
EBITDA 14,186 292,737 303,210 265,122
Net Income 2,854 136,121 131,441 95,826
Total Assets 2,793,381 2,464,101 1,993,080 2,029,256
Total Debt 1,160,674 891,902 471,357 594,021
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Star Lake Bioscience Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Star Lake Bioscience Company Investments & Acquisitions (3)

Star Lake Bioscience Company’s most recent deal was a Merger/Acquisition with Ningxia Eppen Biotech for . The deal was made on 23-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ningxia Eppen Biotech 23-Nov-2022 Merger/Acquisition Agricultural Chemicals
Guangxin Innovation Research Institute 22-Dec-2021 Secondary Transaction - Private Environmental Services (B2B)
Star Lake Bioscience Company (2 Healthcare Manufacturing Operations) 04-Jan-2012 Merger/Acquisition Food Products
To view Star Lake Bioscience Company’s complete investments and acquisitions history, request access »

Star Lake Bioscience Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Star Lake Bioscience Company’s complete esg history, request access »

Star Lake Bioscience Company Exits (2)

Star Lake Bioscience Company’s most recent exit was on 22-Dec-2021 from Guangxin Innovation Research Institute. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Guangxin Innovation Research Institute 22-Dec-2021 Completed
  • 2 buyers
Star Lake Bioscience Company (2 Healthcare Manufacturing Operations) 04-Jan-2012 Merger/Acquisition Completed
To view Star Lake Bioscience Company’s complete exits history, request access »

Star Lake Bioscience Company FAQs

  • When was Star Lake Bioscience Company founded?

    Star Lake Bioscience Company was founded in 1964.

  • Where is Star Lake Bioscience Company headquartered?

    Star Lake Bioscience Company is headquartered in Zhaoqing, China.

  • What is the size of Star Lake Bioscience Company?

    Star Lake Bioscience Company has 10,528 total employees.

  • What industry is Star Lake Bioscience Company in?

    Star Lake Bioscience Company’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Star Lake Bioscience Company a private or public company?

    Star Lake Bioscience Company is a Public company.

  • What is Star Lake Bioscience Company’s stock symbol?

    The ticker symbol for Star Lake Bioscience Company is 600866.

  • What is the current stock price of Star Lake Bioscience Company?

    As of 19-Nov-2026 the stock price of Star Lake Bioscience Company is $0.64.

  • What is the current market cap of Star Lake Bioscience Company?

    The current market capitalization of Star Lake Bioscience Company is $1.06B.

  • What is Star Lake Bioscience Company’s current revenue?

    The trailing twelve month revenue for Star Lake Bioscience Company is $2.34B.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process